SHANGHAI NAT ENGINEERING RES CT OF ANTIBODY MEDICINE CO LTD has a total of 15 patent applications. Its first patent ever was published in 2008. It filed its patents most often in China, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are INNOVATIVE TARGETING SOLUTIONS INC, MURPHY JOHN R and KALOBIOS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 10 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Yajun Guo | 7 |
#2 | Hui Hu | 5 |
#3 | Guo Yajun | 5 |
#4 | Hou Sheng | 5 |
#5 | Hao Wang | 5 |
#6 | Wang Hao | 5 |
#7 | Bohua Li | 4 |
#8 | Min Tan | 4 |
#9 | Li Bohua | 3 |
#10 | Jinqiu Wang | 3 |
Publication | Filing date | Title |
---|---|---|
CN102558315A | Staphylococcal protein A, preparation method thereof and use thereof | |
CN102533919A | Method for efficiently expressing anti-OPN (osteopontin) monoclonal antibody | |
CN102559495A | Medium for high expression of anti-OPN monoclonal antibody | |
CN102329379A | Recombined protein A, coding gene thereof and purpose thereof | |
CN102329840A | Preparation method of recombinant protein A | |
CN102219855A | High-affinity anti-EGFR (epidermal growth factor receptor) monoclonal antibody | |
CN102134277A | Soluble VEGFR (Vascular Endothelial Growth Factor Receptor) difunctional chimera receptor VEGFR31-Ig as well as preparation method and application thereof | |
CN102134276A | Chimeric antibody resisting CTLA-4 (Cytotoxic T Lymphocyte Antigen) | |
AU2009353265A1 | Method of acquiring proteins with high affinity by computer aided design |